Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
ampicillin resistance gene
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| G273E | - | - | - | Imipenem|Meropenem | Reslit | Candidate |
| G154R | - | constitutive activation of ampC expression, ampC hyperproduction, transcriptional regulator AmpR, mutated | Pseudomonas aeruginosa | Penicillin|Cephalosporin|AztreonamCeftazidime|Piperacillin/tazobactamCeftazidime|Cefepime|Ceftolozane/tazobactam|Ceftazidime/avibactam+3 more | Reference Gene CatalogReslit | Confirmed |
| D135A | - | activator | Escherichia coli | Cephalosporin | Reslit | Candidate |
| D135G | - | transcriptional regulator AmpR, single resistance variant | Pseudomonas aeruginosa, Enterococcus faecium | Ceftolozane|TazobactamCEPHALOSPORINAztreonam+2 more | Card DatabaseReference Gene CatalogReslit | Confirmed |
| D135N | transcriptional regulator AmpR, single resistance variant, upregulates AmpC expression | Pseudomonas aeruginosa | Ceftolozane|TazobactamCiprofloxacin|LevofloxacinCEPHALOSPORIN+3 more | Card DatabaseReference Gene CatalogReslit | Confirmed |
| G283E | - | - | Pseudomonas aeruginosa | Ciprofloxacin|LevofloxacinLevofloxacin|CiprofloxacinImipenem|Meropenem+2 more | Reslit | Supported |
| M288R | - | - | Pseudomonas aeruginosa | Ciprofloxacin|LevofloxacinImipenem|MeropenemCeftazidime|Cefepime|Ticarcillin|Imipenem | Reslit | Supported |
| R244W | - | - | Pseudomonas aeruginosa | Imipenem|MeropenemCeftazidime|Cefepime|Ticarcillin|Imipenem | Reslit | Candidate |
| R86C | - | transcriptional regulator AmpR | Pseudomonas aeruginosa | CEPHALOSPORIN | Reference Gene Catalog | Established |
| E273K | - | - | Enterobacter cloacae | Cefoxitin|Cefotaxime|Cefepime|Ertapenem|Imipenem|Meropenem | Reslit | Candidate |
| M1L | - | - | - | Ticarcillin|Piperacillin|Cefepime|Ceftazidime|Aztreonam | Reslit | Candidate |
| D409Y | - | - | Enterobacter cloacae | Cefotaxime | Reslit | Candidate |
| D410A | - | - | Enterobacter cloacae | Cefotaxime | Reslit | Candidate |
| *297Y | - | - | Pseudomonas aeruginosa | Piperacillin | Reslit | Candidate |
| R123Q | - | - | Pseudomonas aeruginosa | Ceftazidime-avibactam|Ceftolozane/tazobactam | Reslit | Candidate |
| H39Y | - | - | Ceftazidime | Reslit | Candidate |
| P164L | - | - | Ceftazidime | Reslit | Candidate |
| L110P | - | - | Ceftazidime | Reslit | Candidate |
| - | - | Pseudomonas aeruginosa | Imipenem|Ampicillin | Reslit | Candidate |
| E274fs | - | - | Ceftazidime | Reslit | Candidate |
Recognition of individual genes in diverse microorganisms by cycling primed in situ amplification.
The study describes the development of CPRINS-FISH for detecting specific genes in bacterial cells, including the ampicillin resistance gene (ampR), chloramphenicol acetyltransferase gene (cat), and the rpoD gene. These genes were successfully detected in various bacterial species, demonstrating the effectiveness of the method for identifying individual genes in complex microbial communities.
Characterization of β-lactamase genes and their regulatory mechanisms in Gram-negative bacteria
The study characterizes the chromosomal β-lactamase gene ampC and its regulatory genes ampR, ampD, ampE, and ampG in various Gram-negative bacteria, highlighting their roles in cephalosporin resistance.
Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems.
The study identified that blaCTX-M-15, blaSHV-12, blaDHA-1, ampR, blaKPC-2, and blaNDM-1 are responsible for carbapenem resistance in Klebsiella pneumoniae. The loss of porins OmpK35 and OmpK36 combined with these genes contributed to resistance against various carbapenems.
Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.
The study identifies AmpR and AmpC as key regulators in β-lactam and non-β-lactam transient cross-resistance in Pseudomonas aeruginosa upon pre-exposure to subinhibitory concentrations of antibiotics.
Multidrug Resistant Pseudomonas aeruginosa Causing Prosthetic Valve Endocarditis: A Genetic-Based Chronicle of Evolving Antibiotic Resistance.
Culture-free bacterial detection and identification from blood with rapid, phenotypic, antibiotic susceptibility testing.
The study demonstrates a culture-free method for rapid detection and identification of bacteria in blood, along with antibiotic susceptibility testing. It highlights the effectiveness of the FEED-based platform in detecting and identifying Escherichia coli and L. innocua, and in determining the susceptibility of E. coli strains to ampicillin and chloramphenicol.
Hospitalized Pets as a Source of Carbapenem-Resistance.
The study identified carbapenem-resistant bacteria in hospitalized pets, including Acinetobacter radioresistens carrying blaNDM-1 and Acinetobacter baumannii carrying blaOXA-23. Mutations in the oprD gene were associated with carbapenem resistance in Pseudomonas aeruginosa, and S. maltophilia exhibited resistance to trimethoprim/sulfamethoxazole due to sul1 and sul2 genes.
Within-Host Adaptation Mediated by Intergenic Evolution in Pseudomonas aeruginosa.
The study identifies intergenic mutations that enhance resistance to beta-lactam antibiotics by increasing the expression of ampR and ampC genes in Pseudomonas aeruginosa.
Prosthetic valve endocarditis caused by Pseudomonas aeruginosa with variable antibacterial resistance profiles: a diagnostic challenge.
The study identifies mutations in ampR, ampD, and oprD genes in Pseudomonas aeruginosa isolates causing prosthetic valve endocarditis, which are associated with variable resistance profiles to ceftazidime, piperacillin-tazobactam, and carbapenems.
Rapid and Ultrasensitive Detection of Mutations and Genes Relevant to Antimicrobial Resistance in Bacteria.
The study presents a nanosensor-based assay for detecting antimicrobial resistance mutations and genes, including ampR D135G and G154R mutations and vanA, vanB, and vanD genes in Pseudomonas aeruginosa and Enterococcus faecium.
Rapid Decline of Ceftazidime Resistance in Antibiotic-Free and Sublethal Environments Is Contingent on Genetic Background.
The study identifies mutations in ampR and rpoB that contribute to the decline of ceftazidime resistance in Pseudomonas aeruginosa under antibiotic-free and sublethal tobramycin environments. These mutations result in reduced β-lactamase activity and restored RpoB functionality, leading to decreased resistance.
Insight into the impacts and mechanisms of ketone stress on the antibiotic resistance in Escherichia coli.
The study found that exposure to methylisobutanone (MIBK) affects the antibiotic resistance in Escherichia coli, particularly highlighting the role of the ampR gene in conferring ampicillin resistance.
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
Cefepime-taniborbactam showed potent in vitro activity against Enterobacterales and P. aeruginosa, particularly effective against isolates with carbapenemase genes such as blaIMP, blaNDM, and blaVIM, as well as those with mutations in ftsI, ompK35, and ompK36.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research